Stephen Liu: Why Having Multiple 3G TKIs Matters in EGFR-Mutated NSCLC

Coverage, in order

1. 6h ago
   
   OncoDaily obscure study n=12

   Stephen Liu: Why Having Multiple 3G TKIs Matters in EGFR-Mutated NSCLC

   Stephen Liu, Chief of Division of Hematology and Oncology at Georgetown Lombardi Comprehensive Cancer Center, shared on X: “Example of why having multiple agents is helpful. Series of 12 patients

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.